$ILMN Company News More reasons to like the Nasdaq in

New Post Public Reply Private Reply Replies (0) Message Board

Sep 11, 2014 at 1:10 PM

$ILMN Company News

More reasons to like the Nasdaq in September 3:14 p.m. Sept. 4, 2014 - The Trading Deck
Good times for stocks lie ahead 1:47 p.m. Aug. 28, 2014 - The Trading Deck
Roche to buy InterMune for $8.3 billion 10:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Raiffeisen rallies, miners slip: Europe movers 12:04 p.m. Aug. 21, 2014 - Sara Sjolin
Miners drop in London after weak China PMI 12:02 p.m. Aug. 21, 2014 - Sara Sjolin
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Growth stocks are doing most bullish thing they can 3:24 p.m. July 1, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
What Apple needs next is this 1:28 p.m. May 8, 2014 - Cody Willard
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
Let Ilumina brighten up your portfolio 4:02 p.m. Jan. 30, 2014 - The Trading Deck
Illumina gets mileage out of earnings as industry declines 11:51 a.m. Jan. 29, 2014 - Russ Britt
Illumina shares up on plan to tap $20 billion gene-sequencing market 1:06 p.m. Jan. 17, 2014 - Russ Britt
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 5:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Illumina shares soar, Waters slides on diverging earnings reports 11:54 a.m. Oct. 22, 2013 - Russ Britt
Charting a sluggish, but bullish, August breakout 11:08 a.m. Aug. 5, 2013 - Michael Ashbaugh
Wednesday’s movers: Robust iPhone data lifts Apple 3:45 p.m. July 24, 2013 - Sue Chang

Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog 3:00 p.m. Sept. 10, 2014 - Zacks.com
10 Best “Strong Buy” Stocks — ILMN EQM XRS and more 4:15 a.m. Sept. 10, 2014 - InvestorPlace.com
Quiet Stocks Are Typical In Market Right Now 5:18 p.m. Sept. 8, 2014 - Investors Business Daily
Why Illumina (ILMN) Stock Is Gaining Today 10:56 a.m. Sept. 8, 2014 - TheStreet.com
IBD 50 Showing Little Distress, But Few Big Winners 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog 4:45 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog 5:00 p.m. Sept. 4, 2014 - Zacks.com
3 Stocks Advancing The Health Care Sector 1:03 p.m. Sept. 4, 2014 - TheStreet.com
Transgenomic's Niche In Illumina's Universe 11:58 a.m. Sept. 4, 2014 - Seeking Alpha
Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead 5:28 p.m. Sept. 3, 2014 - Investors Business Daily
10 Best “Strong Buy” Stocks — LUV ILMN XRS and more 4:30 a.m. Sept. 3, 2014 - InvestorPlace.com
Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% - Tale of the Tape 8:44 a.m. Sept. 2, 2014 - Zacks.com
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch 7:02 a.m. Aug. 27, 2014 - Investors Business Daily
More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News 4:43 p.m. Aug. 25, 2014 - Zacks.com
The 4 Companies Teaming Up For A New Tool To Fight Cancer 3:03 p.m. Aug. 25, 2014 - benzinga.com
Roche to Acquire Biotech Firm 12:00 p.m. Aug. 24, 2014 - The Wall Street Journal Interactive Edition
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Illumina Joins Drugmakers To Make Cancer Test System 5:57 p.m. Aug. 22, 2014 - Investors Business Daily

Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Sept. 9, 2014 - GlobeNewswire
Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions 6:30 a.m. Sept. 8, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 9:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Aug. 27, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018 6:02 p.m. Aug. 25, 2014 - PR Newswire - PRF
The Global Non-Invasive Prenatal Diagnostics Market 1:12 p.m. Aug. 19, 2014 - PR Newswire - PRF
Life Sciences Tools and Services Stocks in Motion -- Affymetrix, Agilent Technologies, Bruker, Illumina, and Sequenom 8:40 a.m. Aug. 18, 2014 - PR Newswire - PRF
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina 8:50 a.m. Aug. 11, 2014 - PR Newswire - PRF
New Product Launch, New Board Member, Major Contracts, Successful Testing, and Grants - Research Reports on Abbott, Illumina, General Dynamics, Raytheon and Northrop Grumman 8:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases 7:05 p.m. July 31, 2014 - BusinessWire - BZX
Illumina Appoints Jeff Huber to its Board of Directors 6:30 a.m. July 31, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 5:38 p.m. July 28, 2014 - PR Newswire - PRF
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 4:07 p.m. July 23, 2014 - BusinessWire - BZX
Sidra to Help Qatar Grow as a Hub for Genetic Medicine 7:45 a.m. July 22, 2014 - BusinessWire - BZX
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese Regulatory Agency 6:30 a.m. July 21, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

World Fire Congress 2026 Champions Global Fire Safety

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

XKL Delivers MediaLight for High-Speed Optical Transport

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...